Fish Oil-Based IV Nutrition Linked to Fewer Infections and Shorter Hospital Stays
This research combined results from 47 clinical trials to compare different types of intravenous lipid emulsions used in parenteral (IV) nutrition for hospitalized adults. Researchers compared four categories: fish oil-based emulsions, olive oil-based emulsions, soybean oil with medium-chain triglycerides, and pure soybean oil emulsions.
Using a statistical technique called network meta-analysis, which allows indirect comparisons across multiple treatment types at once, the researchers found that fish oil-containing emulsions were associated with meaningfully lower rates of infection and sepsis compared to the other three emulsion types. Patients receiving fish oil-based IV lipids also tended to have shorter hospital stays.
When ranked across all five outcomes studied, including infections, sepsis, ICU stay length, hospital stay length, and in-hospital mortality, fish oil-based emulsions consistently ranked first compared to the alternatives.
What this means for you
For hospitalized patients who require IV (parenteral) nutrition rather than eating normally, this analysis suggests that the type of fat included in that nutrition may matter for recovery-related outcomes like infection risk and length of hospital stay. This is a clinical/hospital nutrition context rather than everyday dietary supplementation, but it adds to the broader body of evidence on how omega-3 fats from fish oil may support the body during acute illness or surgery.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Clinical nutrition (Edinburgh, Scotland) · 2023-04-01 · DOI: 10.1016/j.clnu.2023.02.008
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.